IE
Insider Edges

RANGELEY CAPITAL, LLC 13F portfolio summary

RANGELEY CAPITAL, LLC of RANGELEY CAPITAL, LLC has 183 current stock holdings with a reported portfolio value of $109.5M. The portfolio 1 year return is +34.43%. Top holdings include DRVN (6.60%), PRTA (3.73%), SEG (3.73%), GRND (2.89%), STHO (2.71%).

Back to investors

RANGELEY CAPITAL, LLC

RANGELEY CAPITAL, LLC
Latest filing: 2026-06-30

RANGELEY CAPITAL, LLC runs RANGELEY CAPITAL, LLC and currently holds 183 stock positions, which is fewer than the average of 230 among the investors we track. The portfolio is valued at approximately $109.46M. Their top holdings are DRVN, PRTA, SEG, GRND, STHO. The top five represent 19.7% of reported portfolio weight. RANGELEY CAPITAL, LLC ranks #N/A out of 1000 investors tracked by Alpha Score. In the most recent quarter, RANGELEY CAPITAL, LLC initiated 29 new positions. They added to 11 existing positions. They trimmed 24 positions. Their current best-performing preview position is RVMD with returns of +485.73%.

Sign in to enable email alerts for this investor.
Top 5 Holdings
DRVN6.6%
PRTA3.7%
SEG3.7%
GRND2.9%
STHO2.7%
Top 5: 19.7%
Portfolio Returns
1 Year
+34.43%
#0/1000
3 Year
+25.71%
#0/1000
5 Year
+25.71%
#0/1000

Portfolio Value

$109.46M

Alpha Score

26.3

#0 of 1000

Holdings

183

Showper page

183 stock holdings

HoldingWeightAvg BuyCurrentReturnQuarter Change
DRVN
DRIVEN BRANDS HLDGS INC
6.60%$12.61$13.17+4.44%
Trimmed
-17.15%
PRTA
PROTHENA CORP PLC
3.73%$6.07$9.45+55.68%
Trimmed
-7.16%
SEG
SEAPORT ENTMT GROUP INC
3.73%$27.74$26.80-3.39%
Held
GRND
GRINDR INC
2.89%$13.40$15.55+16.04%
Trimmed
-5.98%
STHO
STAR HLDGS
2.71%$8.73$9.79+12.14%
Added
+18.37%
ABUS
ARBUTUS BIOPHARMA CORP
2.19%$3.27$5.21+59.33%
Held
TRIP
TRIPADVISOR INC
1.90%$10.66$10.00-6.19%
Trimmed
-20.00%
SATS
ECHOSTAR CORP
1.69%$77.71$86.98+11.93%
Trimmed
-1.11%
ABVX
ABIVAX SA
1.58%$118.38$114.95-2.90%
Added
+225.00%
GDOT
GREEN DOT CORP
1.57%$11.22$13.45+19.88%
Trimmed
-21.59%

Showing 1-10 of 183